Olanzapine (5 mg) plus standard triple antiemetic therapy for the prevention of multiple-day cisplatin hemotherapy-induced nausea and vomiting: a prospective randomized controlled study

HIGHLIGHTS

• who: Jiali Gao from the In summary, mg olanzapine plus tropisetron and dexamethasone, omitting aprepitant therapy, may be an alternative regimen in prevention of CINV induced by multipleday cisplatin chemotherapyLarger sample sizes of clinical studies are ongoing to further confirm the advantage of aprepitant on the basis of , mg olanzapine combined with new generation of, HT RA palonosetron and NK- RA fosaprepitant for the prevention of CINV induced by multiple-day cisplatin chemotherapy. Author contribution GJ participated in supervision, project administration and funding acquisition. QL participated in writing, original draft, conceptualization, methodology, funding acquisition, and software. JG . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.